GREGORY A GOULD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY A GOULD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY A GOULD. GREGORY A GOULD is Chief Financial Officer in ATRIX LABORATORIES INC ($ATRX) and Director in CytoDyn Inc. ($CYDY) and Chief Financial Officer in AYTU BIOSCIENCE, INC ($RSWN) and Chief Financial Officer in Ampio Pharmaceuticals, Inc. ($AMPE) and CFO in New Age Beverages Corp ($NBEV) and Chief Financial Officer in New Age Beverages Corp ($NBEV).
Latest Insider Trading Transactions of GREGORY A GOULD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMPE, ATRX, AYTU, CYDY, NBEV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 2.79 | 125,000 | 348,750 | 125,000 | |
| Jan 05 2021 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 2.63 | 26,507 | 69,713 | 404,365 | 430.9 K to 404.4 K (-6.15 %) |
| Dec 11 2020 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 3.16 | 9,564 | 30,222 | 430,872 | 440.4 K to 430.9 K (-2.17 %) |
| Oct 26 2020 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 2.72 | 9,564 | 26,014 | 440,436 | 450 K to 440.4 K (-2.13 %) |
| Dec 12 2019 | NBEV | New Age Beverages ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
| Dec 12 2019 | NBEV | New Age Beverages ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 450,000 | 350 K to 450 K (+28.57 %) |
| Jul 03 2019 | NBEV | New Age Beverages ... | Gould Gregory A | CFO | Option Exercise | A | 4.75 | 100,000 | 475,000 | 100,000 | |
| Jul 03 2019 | NBEV | New Age Beverages ... | Gould Gregory A | CFO | Grant | A | 0.00 | 250,000 | 0 | 350,000 | 100 K to 350 K (+250.00 %) |
| Jul 03 2019 | NBEV | New Age Beverages ... | Gould Gregory A | CFO | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Jun 19 2019 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.52 | 100,000 | 52,000 | 100,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.49 | 100,000 | 49,000 | 100,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.80 | 50,000 | 40,000 | 50,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.56 | 160,662 | 89,971 | 160,662 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.57 | 75,000 | 42,750 | 75,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.68 | 100,000 | 68,000 | 100,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 1.09 | 50,000 | 54,500 | 50,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.98 | 50,000 | 48,750 | 50,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 1.55 | 25,000 | 38,750 | 25,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
| Nov 19 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Grant | A | 0.00 | 19,176 | 0 | 19,176 | 0 to 19.2 K |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.49 | 100,000 | 49,000 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.80 | 50,000 | 40,000 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.56 | 160,662 | 89,971 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.57 | 75,000 | 42,750 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.68 | 100,000 | 68,000 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 1.09 | 50,000 | 54,500 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.98 | 50,000 | 48,750 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 1.55 | 25,000 | 38,750 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 2.00 | 50,000 | 100,000 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.66 | 50,000 | 33,000 | 0 | |
| Nov 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Sell | D | 0.00 | 19,176 | 0 | 0 | 19.2 K to 0 (-100.00 %) |
| Jun 12 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.49 | 100,000 | 49,000 | 100,000 | |
| Feb 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.80 | 50,000 | 40,000 | 50,000 | |
| Feb 16 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.80 | 50,000 | 40,000 | 0 | |
| Feb 09 2018 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.56 | 160,662 | 89,971 | 160,662 | |
| Jun 05 2017 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.57 | 75,000 | 42,750 | 75,000 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 0.82 | 25,000 | 20,500 | 25,000 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 0.82 | 20,834 | 17,084 | 20,834 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 3.23 | 25,000 | 80,750 | 0 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 3.23 | 20,834 | 67,294 | 0 | |
| Mar 01 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | M | 1.86 | 66,666 | 123,999 | 0 | |
| Mar 01 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Buy | M | 0.75 | 66,666 | 50,000 | 340,231 | 273.6 K to 340.2 K (+24.37 %) |
| Nov 21 2016 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.68 | 100,000 | 68,000 | 100,000 | |
| Nov 04 2016 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | P | 1.86 | 66,666 | 123,999 | 66,666 | |
| Nov 04 2016 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Buy | P | 1.50 | 66,666 | 99,999 | 273,565 | 206.9 K to 273.6 K (+32.22 %) |
| Aug 04 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 41,899 | 0 | 206,899 | 165 K to 206.9 K (+25.39 %) |
| Jul 19 2016 | AMPE | Ampio Pharmaceutic ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.03 | 150,000 | 154,500 | 416,666 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 3.23 | 25,000 | 80,750 | 25,000 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 3.23 | 20,834 | 67,294 | 20,834 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 18.12 | 20,834 | 377,512 | 0 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 165,000 | 0 | 165,000 | 0 to 165 K |
| Jun 03 2016 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 1.09 | 50,000 | 54,500 | 50,000 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.98 | 50,000 | 48,750 | 50,000 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 0.98 | 50,000 | 48,750 | 0 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 1.55 | 25,000 | 38,750 | 25,000 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 1.55 | 25,000 | 38,750 | 0 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
| Dec 23 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | D | 2.00 | 50,000 | 100,000 | 0 | |
| Nov 13 2015 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.51 | 250,000 | 377,500 | 250,000 | |
| Aug 03 2015 | AMPE | Ampio Pharmaceutic ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 2.60 | 100,000 | 260,000 | 100,000 | |
| Jun 02 2015 | CYDY | CytoDyn Inc. | Gould Gregory A | Director | Option Exercise | A | 0.98 | 50,000 | 48,750 | 50,000 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | GOULD GREGORY A | Chief Financial Off ... | Option Exercise | A | 31.00 | 30,000 | 930,000 | 30,000 | |
| Feb 05 2004 | ATRX | ATRIX LABORATORIES ... | GOULD GREGORY A | Chief Financial Off ... | Option Exercise | A | 24.96 | 12,019 | 299,994 | 12,019 | |
| Feb 05 2004 | ATRX | ATRIX LABORATORIES ... | GOULD GREGORY A | Chief Financial Off ... | Option Exercise | A | 24.96 | 32,981 | 823,206 | 32,981 |
Page: 1